ibrutinib (brand/generic not specified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ibrutinib (brand/generic not specified), covering 2022-04-07 to 2022-04-07. Get the full timeline:
Most recent: Clinical Trial Update: Ibrutinib With Methotrexate and Temozolomide for Patients With Newly Diagnosed Primary CNS Lymphoma [Phase 2]